Fredun Pharmaceuticals Ltd.

Financial

	Fredun Pharma	Medicamen Biotech	Albert David
Operational Metrics
Financials
5 yr Average ROE	8.53 %	8.49 %	11.47 %
5yr average Equity Multiplier	3.02	1.47	1.63
5yr Average Asset Turnover Ratio	1.01	0.58	0.62
5yr Avg Net Profit Margin	2.89 %	10.0 %	11.31 %
Price to Book	3.6	2.38	1.18
P/E	21.71	71.38	73.74
5yr Avg Cash Conversion Cycle	137.13 Days	13.14 Days	-77.77 Days
Inventory Days	140.46 Days	66.66 Days	47.91 Days
Days Receivable	52.11 Days	122.66 Days	27.87 Days
Days Payable	131.93 Days	257.34 Days	140.35 Days
5yr Average Interest Coverage Ratio	2.31	10.36	93.73
5yr Avg ROCE	16.75 %	12.12 %	14.69 %
5yr Avg Operating Profit Margin	8.32 %	16.84 %	9.55 %
5 yr average Debt to Equity	0.86	0.14	0.02
5yr CAGR Net Profit	52.4 %	-6.51 %	-4.92 %
5yr Average Return on Assets	3.05 %	5.75 %	7.03 %
Shareholdings
Promoter Holding	48.93 %	40.46 %	62.24 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.11 %	-3.14 %	0.25 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Fredun Pharma	Medicamen Biotech	Albert David
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceuticals Formulations 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceuticals Formulations 100.0 Pharmaceutical 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceuticals Formulations 0 Pharmaceutical 0 Pharmaceutical 100.0
Location Wise Break-Up	Location Wise Break-Up India 77.22 Rest of the World 22.32 Others 0.46	Location Wise Break-Up Rest of the World 0 India 20.0 Others 80.0	Location Wise Break-Up Rest of the World 6.76 India 93.24